- Home
- ETON vs SCHL Comparison
ETON vs SCHL Comparison
Compare ETON & SCHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETON
- SCHL
- Stock Information
- Founded
- ETON 2017
- SCHL 1920
- Country
- ETON United States
- SCHL United States
- Employees
- ETON N/A
- SCHL N/A
- Industry
- ETON Biotechnology: Pharmaceutical Preparations
- SCHL Books
- Sector
- ETON Health Care
- SCHL Consumer Discretionary
- Exchange
- ETON Nasdaq
- SCHL Nasdaq
- Market Cap
- ETON 428.5M
- SCHL 478.8M
- IPO Year
- ETON 2018
- SCHL 1987
- Fundamental
- Price
- ETON $13.75
- SCHL $21.26
- Analyst Decision
- ETON Strong Buy
- SCHL
- Analyst Count
- ETON 3
- SCHL 0
- Target Price
- ETON $29.67
- SCHL N/A
- AVG Volume (30 Days)
- ETON 457.7K
- SCHL 286.8K
- Earning Date
- ETON 08-07-2025
- SCHL 07-17-2025
- Dividend Yield
- ETON N/A
- SCHL 3.75%
- EPS Growth
- ETON N/A
- SCHL N/A
- EPS
- ETON N/A
- SCHL 0.65
- Revenue
- ETON $48,327,000.00
- SCHL $1,592,100,000.00
- Revenue This Year
- ETON $103.21
- SCHL $3.42
- Revenue Next Year
- ETON $51.34
- SCHL $5.47
- P/E Ratio
- ETON N/A
- SCHL $32.69
- Revenue Growth
- ETON 40.88
- SCHL N/A
- 52 Week Low
- ETON $3.19
- SCHL $15.77
- 52 Week High
- ETON $21.48
- SCHL $38.77
- Technical
- Relative Strength Index (RSI)
- ETON 26.60
- SCHL 67.62
- Support Level
- ETON $13.09
- SCHL $18.45
- Resistance Level
- ETON $14.18
- SCHL $22.03
- Average True Range (ATR)
- ETON 0.78
- SCHL 0.92
- MACD
- ETON -0.23
- SCHL 0.32
- Stochastic Oscillator
- ETON 8.78
- SCHL 75.06
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
About SCHL Scholastic Corporation
Scholastic Corp is an American publishing and education media company that focuses on books and educational material for schools, teachers, parents, and children. It creates print, digital, and audiobooks, learning materials and programs, classroom magazines, and other products that support children's learning and reading both at home and at school. The company also owns rights to various books, including Harry Potter, Dog Man, and The Hunger Games among others. It has three reportable segments Children's Book Publishing and Distribution, Education Solutions, and International. The majority of its revenue is from the Children's Book Publishing and Distribution segment.